John B. Bode

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
4 years
Director since
2023

4 years of board service in total across 3 boards, counting each seat separately. Longest: Zevra Therapeutics Inc., 3 years.

3 years · Since 2023
7 months · Since 2026
Stewards Inc Director
3 weeks · Since 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Mar 24, 2026 Zevra Therapeutics Inc. Option exercise +39,200 $4.97 $194,824
Mar 24, 2026 Zevra Therapeutics Inc. Option exercise +39,200 $4.89 $191,688
Jan 30, 2026 Newton Golf Company Inc. Grant or award +18,549 — —
Aug 19, 2025 Zevra Therapeutics Inc. Open-market purchase +5,000 $9.17 $45,850
Mar 19, 2025 Zevra Therapeutics Inc. Open-market purchase +10,000 $7.96 $79,600
Jul 12, 2024 Zevra Therapeutics Inc. Open-market purchase +10,000 $5.87 $58,700
Sep 5, 2023 Zevra Therapeutics Inc. Open-market purchase +10,000 $5.13 $51,300
May 18, 2023 Zevra Therapeutics Inc. Open-market purchase +1,390 $5.04 $7,006
May 18, 2023 Zevra Therapeutics Inc. Open-market purchase +300 $5.04 $1,512
May 18, 2023 Zevra Therapeutics Inc. Open-market purchase +1,000 $5.04 $5,040
May 18, 2023 Zevra Therapeutics Inc. Open-market purchase +4,759 $5.04 $23,985
May 18, 2023 Zevra Therapeutics Inc. Open-market purchase +100 $5.05 $505
May 18, 2023 Zevra Therapeutics Inc. Open-market purchase +2,451 $5.05 $12,378

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.